Economic Atlas
Companies/Emmaus Life Sciences, Inc.
Company profile

Emmaus Life Sciences, Inc.

OTC: EMMA · Healthcare · Biotechnology
PublicHQ Torrance, CA · Los AngelesCIK 0000822370Reports USD
#606 of 1,418 Healthcare companies by revenue26th-percentile growth
EA Score
40D
Revenue TTM
$12.0M
Rev growth YoY (TTM)
-27.3%
Net income (FY)
-$7.5M
Employees
33
as of 2026-08-26
Market cap
$2.7M
as of 2026-08-26

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$12.5M$12.5M2025
Net income-$7.5M-$7.5M2025
Operating income$231.0k$231.0k2025
Total assets$21.4M$21.4M2025
Liabilities$85.0M$85.0M2025
Equity-$63.6M-$63.6M2025

Revenue trend

FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product and Service, Other100%
By geography

Not disclosed.

The read

What is Emmaus Life Sciences, Inc.’s revenue?

Emmaus Life Sciences, Inc. booked $12.5M in FY2025 revenue, contracting 25% year over year — slower than 74% of Healthcare companies we track, at a -60.2% net margin.

Peers · Healthcare
NexgenRx Inc.71BClearday, Inc.——Medical Marijuana, Inc.58CElutia Inc52DDevonian Health Group Inc.46DPrelude Therapeutics Incorporated37D
Neighbors
Los Angeles →
The Walt Disney Company$94.4B72BPublic Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68BLive Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D
Key facts
CEOWillis C. Lee
SectorHealthcare
IndustryBiotechnology
HeadquartersTorrance, CA
ExchangeOTC: EMMA
Employees33
IPO date2000-05-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.